| The applications of PET in clinical oncology LG Strauss, PS Conti Journal of nuclear medicine 32 (4), 623-648, 1991 | 1218 | 1991 |
| Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients LG Strauss European journal of nuclear medicine 23, 1409-1415, 1996 | 681 | 1996 |
| Recurrence of colorectal tumors: PET evaluation. LG Strauss, JH Clorius, P Schlag, B Lehner, B Kimmig, R Engenhart, ... Radiology 170 (2), 329-332, 1989 | 360 | 1989 |
| PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy U Haberkorn, LG Strauss, A Dimitrakopoulou, R Engenhart, F Oberdorfer, ... Journal of Nuclear Medicine 32 (8), 1485-1490, 1991 | 356 | 1991 |
| Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry U Haberkorn, LG Strauss, CH Reisser, D Haag, A Dimitrakopoulou, ... Journal of Nuclear Medicine 32 (8), 1548-1555, 1991 | 321 | 1991 |
| Three dimensional image correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors LR Schad, R Boesecke, W Schlegel, GH Hartmann, V Sturm, LG Strauss, ... Journal of computer assisted tomography 11 (6), 948-954, 1987 | 266 | 1987 |
| Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas MHM Schwarzbach, A Dimitrakopoulou-Strauss, F Willeke, U Hinz, ... Annals of surgery 231 (3), 380-386, 2000 | 238 | 2000 |
| Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas M Henze, A Dimitrakopoulou-Strauss, S Milker-Zabel, J Schuhmacher, ... Journal of Nuclear Medicine 46 (5), 763-769, 2005 | 204 | 2005 |
| Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy U Haberkorn, LG Strauss, A Dimitrakopoulou, E Seiffert, F Oberdorfer, ... Journal of Nuclear Medicine 34 (1), 12-17, 1993 | 202 | 1993 |
| The role of quantitative 18F-FDG PET studies for the differentiation of malignant and benign bone lesions A Dimitrakopoulou-Strauss, LG Strauss, T Heichel, H Wu, C Burger, ... Journal of Nuclear Medicine 43 (4), 510-518, 2002 | 184 | 2002 |
| Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading A Dimitrakopoulou-Strauss, LG Strauss, M Schwarzbach, C Burger, ... Journal of Nuclear Medicine 42 (5), 713-720, 2001 | 182 | 2001 |
| Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy S Koukouraki, LG Strauss, V Georgoulias, M Eisenhut, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 33, 1115-1122, 2006 | 178 | 2006 |
| Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F] fluoro-L-dopa with 18F-FDG and 15O-water using compartment and noncompartment analysis A Dimitrakopoulou-Strauss, LG Strauss, C Burger Journal of Nuclear Medicine 42 (2), 248-256, 2001 | 177 | 2001 |
| Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy S Koukouraki, LG Strauss, V Georgoulias, J Schuhmacher, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 33, 460-466, 2006 | 159 | 2006 |
| 68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG A Dimitrakopoulou-Strauss, P Hohenberger, U Haberkorn, HR Mäcke, ... Journal of Nuclear Medicine 48 (8), 1245-1250, 2007 | 139 | 2007 |
| Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas MHM Schwarzbach, U Hinz, A Dimitrakopoulou-Strauss, F Willeke, ... Annals of surgery 241 (2), 286-294, 2005 | 126 | 2005 |
| Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience P Ströbel, R Bargou, A Wolff, D Spitzer, C Manegold, ... British journal of cancer 103 (2), 196-200, 2010 | 120 | 2010 |
| Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy A Dimitrakopoulou-Strauss, LG Strauss, C Burger, A Rühl, G Irngartinger, ... Journal of Nuclear Medicine 45 (9), 1480-1487, 2004 | 117 | 2004 |
| Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas A Dimitrakopoulou-Strauss, LG Strauss, H Goldschmidt, WJ Lorenz, ... European journal of nuclear medicine 22, 434-442, 1995 | 117 | 1995 |
| 18F‐labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5‐fluorouracil M Moehler, A Dimitrakopoulou‐Strauss, F Gutzler, U Raeth, LG Strauss, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 109 | 1998 |
